smvt-1

There is 1 paper on smvt-1 in aging research: none in people yet, 1 in animals. The newest story, Nov 2, 2026: “Diabetes drug prolonged lifespan in glucose-fed worms”.

Gene

1 paper studies it1 finding

NCBI GeneTaxon

See all 1 papers on smvt-1

At a glance

The findings reach worms or flies, none yet in people. 1 lab in 2 countries.

Worms or flies: a single group. Cells, mice and humans: nothing yet.
  • 1 lab in 2 countries
  • Model organisms1

Effects

1

Glucose transport

is required forin worms1

1 study
  1. smvt-1 is required for glucose transport in worms (dapagliflozin-mediated inhibition, shown by smvt-1 knockdown).

    “Notably, this inhibitory effect was abolished upon downregulation of smvt-1”

    Model organismsdapagliflozin-mediated inhibition, shown by smvt-1 knockdown

    Diabetes drug prolonged lifespan in glucose-fed worms

    Endokrynologia Polska

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Endokrynologia Polska

Diabetes drug prolonged lifespan in glucose-fed worms

Dapagliflozin also reduced glucose transport in laboratory experiments with worms that lack an equivalent of the drug’s usual target.Dapagliflozin also reduced glucose transport in laboratory experiments with worms that lack an equivalent of the drug’s usual target.

Worm studyInterventions